For patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for liver transplant, liver resection provides a survival advantage over percutaneous radiofrequency ablation and ...
The efficacy and safety of donafenib combined with TACE as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after radical resection: A retrospective study. Median, ...
In patients with recurrent small hepatocellular carcinoma (HCC), stereotactic body radiotherapy (SBRT) demonstrated superior local progression-free survival (PFS) and tumor control at 3 years compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results